Evidence map›Paper›PMID 29285574›Full record

ArticleCellular and molecular life sciences : CMLS2018

Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

Gabrio Bassotti, Lara Macchioni, Lanfranco Corazzi, Pierfrancesco Marconi, Katia Fettucciari

Open access · bronzeAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2023
    Review
  3. Cytotoxic synergism ofWorld journal of gastroenterology · 2023
    Review
  4. Article
  5. Article
  6. Nutraceuticals and Enteric Glial Cells.Molecules (Basel, Switzerland) · 2021
    Review
  7. Journal of inflammation research · 2021
    Article
  8. Article
  9. Invisible steps for a global endemy: molecular strategies adopted byTherapeutic advances in gastroenterology · 2021
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gabrio BassottiDepartment of Medicine, University of Perugia Medical School, Perugia, Italy. gabassot@tin.it.ORCID 0000-0002-0237-1812
Lara MacchioniDepartment of Experimental Medicine, University of Perugia Medical School, Perugia, Italy.
Lanfranco CorazziDepartment of Experimental Medicine, University of Perugia Medical School, Perugia, Italy.
Pierfrancesco MarconiDepartment of Experimental Medicine, University of Perugia Medical School, Perugia, Italy.
Katia FettucciariDepartment of Experimental Medicine, University of Perugia Medical School, Perugia, Italy.
University of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-infectious irritable bowel syndrome is a well-defined pathological entity that develops in about one-third of subjects after an acute infection (bacterial, viral) or parasitic infestation. Only recently it has been documented that an high incidence of post-infectious irritable bowel syndrome occurs after Clostridium difficile infection. However, until now it is not known why in some patients recovered from this infection the gastrointestinal disturbances persist for months or years. Based on our in vitro studies on enteric glial cells exposed to the effects of C. difficile toxin B, we hypothesize that persistence of symptoms up to the development of irritable bowel syndrome might be due to a disturbance/impairment of the correct functions of the enteroglial intestinal network.

Indexed as

Bacterial ProteinsBacterial ToxinsClostridioides difficileClostridium InfectionsEnteric Nervous SystemHost-Pathogen InteractionsHumansIntestinal MucosaIrritable Bowel SyndromeModels, TheoreticalNeurogliaRisk FactorsBacterial ProteinsBacterial ToxinstoxB protein, Clostridium difficileClostridium difficileEnteric glial cellsPost-infectious irritable bowel syndromeToxin B

Identifiers

PMID29285574
PMCPMC11105427
OpenAlexW2776242107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.